Previous 10 | Next 10 |
SPDR S&P 600 Small Cap Growth ETF (NYSEARCA: SLYG ) - $0.2134 . 30-Day SEC Yield of 1.05%. SPDR S&P 500 Small Cap Growth ETF (NYSEARCA: SPYG ) - $0.1222 . 30-Day SEC Yield of 1.43%. SPDR S&P 500 Value ETF (NYSEARCA: SPYV ) - $0.1753 . 30-Day SEC Yield of 2.44%. SPDR S&am...
With New Year's celebrations barely winding down, 2019 started with a bang with the announcement of the largest ever U.S. pharmaceutical deal. The news of Bristol-Myers Squibb ( BMY ) acquiring Celgene ( CELG ) immediately caused BMY stock to drop over 13% from $52.02 to $45.12 while Celgene s...
With yet another US Senate hearing having been held in late February , prescription drug prices have been continuously receiving a lot of attention. While an eventual solution to brand name pricing may take a number of years, changes to the generic industry may be coming quicker. Over the pas...
By Ethan Lovell and Rich Carney, CFA The U.S. Department of Health and Human Services wants to eliminate drug manufacturer rebates in Medicare, a move that could improve affordability for consumers. Portfolio Manager Ethan Lovell and Research Analyst Rich Carney, of the Global Life Scienc...
The Healthcare sector ranks seventh out of the 11 sectors as detailed in our Q1'19 Sector Ratings for ETFs and Mutual Funds report. Last quarter , the Healthcare sector ranked third. It gets our Neutral rating, which is based on an aggregation of ratings of the 323 stocks in the Healthcare ...
According to the Centers for Medicare & Medicaid Services (CMS), U.S. healthcare spending is expected to rise 5.5% each year over the next decade, reaching ~$6T by 2027 (19.4% of GDP). More news on: ProShares Ultra Nasdaq Biotechnology ETF, The Gabelli Healthcare & Wellness Rx Tr...
For those of you investing in Big Pharma, you may want to keep a close eye on developments in Washington over the next two years. The cost of pharmaceuticals may very well be the number one issue leading up to the 2020 election, and this year it may very well be different. This year, the Dem...
The U.S. Supreme Court has rejected the state of Maryland's appeal of an appeals court ruling that struck down its anti-price gouging law citing the illegality of state-level regulation of interstate commerce. More news on: Health Care Select Sect SPDR ETF, iShares Nasdaq Biotechnology E...
In a statement , FDA commissioner Scott Gottlieb, M.D. announces a new pathway for accelerated view of marketing applications from generic drugmakers for off-patent branded medicines facing no generic competition, a situation characterizing "hundreds" of such drugs that serve small patient ...
The recently announced deal of Bristol-Myers Squibb ( BMY ) acquiring Celgene ( CELG ) got me thinking about biotech & big pharma stocks. The following chart perfectly sums up why I believe big pharma will continue to be acquirers of large-cap biotech companies and small/mid cap companies....
News, Short Squeeze, Breakout and More Instantly...
SPDR S&P Pharmaceuticals Company Name:
XPH Stock Symbol:
NYSE Market:
Second Quarter 2024 Highlights: Record sales of $3.61 billion, up 18% in U.S. dollars and 11% organically compared to the second quarter of 2023 GAAP Diluted EPS of $0.41, up 11% compared to prior year Record Adjusted Diluted EPS of $0.44, up 22% compared to prior year ...
2024-07-19 12:54:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Transaction highlights: To acquire CommScope’s Outdoor Wireless Networks and Distributed Antenna Systems businesses for $2.1 billion in cash Adds advanced antenna and associated interconnect products, technologies and capabilities Complements Amphenol’s existing prod...